Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| IDE | P14735 | Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin) | EnzymesFDA approved drug targetsPlasma proteins | Inherited retinal dystrophySkin and skin-structure infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.47 | |||
| ITA11 | Q9UKX5 | Integrin alpha-11 | Predicted membrane proteinsTransporters | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 0 | 0.47 | |||
| ITA2 | P17301 | Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b) | Cancer-related genesCD markersHuman disease related genes | 1 | Colorectal cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 0 | 0.47 | ||
| KCAB2 | Q13303 | Voltage-gated potassium channel subunit beta-2 (EC 1.1.1.-) (K(+) channel subunit beta-2) (Kv-beta-2) (hKvbeta2) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationImmune mediation | 0 | 0.47 | ||||
| KCMA1 | Q12791 | Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo) | Disease related genesFDA approved drug targetsHuman disease related genes | 7 | EpilepsyAsthmaFunctional bladder disorder | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.47 | ||
| LIN7A | O14910 | Protein lin-7 homolog A (Lin-7A) (hLin-7) (Mammalian lin-seven protein 1) (MALS-1) (Tax interaction protein 33) (TIP-33) (Vertebrate lin-7 homolog 1) (Veli-1) | Predicted intracellular proteins | Fusion and delivery mediation | 0 | 0.47 | ||||
| LIN7C | Q9NUP9 | Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3) | Predicted intracellular proteins | Fusion and delivery mediation | 0 | 0.47 | ||||
| MRP8 | Q96J66 | ATP-binding cassette sub-family C member 11 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 8) | 12 | Clinical-translation mediationFusion and delivery mediation | 0 | 0.47 | ||||
| SUIS | P14410 | Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] | Disease related genesEnzymesFDA approved drug targets | 1 | Clinical-translation mediationFusion and delivery mediation | 0 | 0.47 | |||
| GLUT4 | P14672 | Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4) | Disease related genesMetabolic proteinsPotential drug targets | 12 | Diabetes mellitusType 2 diabetes mellitus | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 5 | 0.40 |